BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 27251903)

  • 1. Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study.
    Hill SL; Najafi J; Dunn M; Acheampong P; Kamour A; Grundlingh J; Blain PG; Thomas SH
    Clin Toxicol (Phila); 2016 Sep; 54(8):638-43. PubMed ID: 27251903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis and clinical findings of cases positive for the novel synthetic cannabinoid receptor agonist MDMB-CHMICA.
    Seywright A; Torrance HJ; Wylie FM; McKeown DA; Lowe DJ; Stevenson R
    Clin Toxicol (Phila); 2016 Sep; 54(8):632-7. PubMed ID: 27213960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project.
    Bäckberg M; Tworek L; Beck O; Helander A
    J Med Toxicol; 2017 Mar; 13(1):52-60. PubMed ID: 27638057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
    Franz F; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDMB-CHMICA: Availability, Patterns of Use, and Toxicity Associated With This Novel Psychoactive Substance.
    Haden M; Archer JR; Dargan PI; Wood DM
    Subst Use Misuse; 2017 Jan; 52(2):223-232. PubMed ID: 27759479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and clinical features of toxicity following recreational use of synthetic cannabinoid receptor agonists: a report from the United Kingdom National Poisons Information Service.
    Waugh J; Najafi J; Hawkins L; Hill SL; Eddleston M; Vale JA; Thompson JP; Thomas SH
    Clin Toxicol (Phila); 2016 Jul; 54(6):512-8. PubMed ID: 27091041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.
    Hermanns-Clausen M; Müller D; Kithinji J; Angerer V; Franz F; Eyer F; Neurath H; Liebetrau G; Auwärter V
    Clin Toxicol (Phila); 2018 Jun; 56(6):404-411. PubMed ID: 29072524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Toxicity Caused by Indole and Indazole Carboxylate Synthetic Cannabinoid Receptor Agonists: From Horizon Scanning to Notification.
    Hill SL; Dunn M; Cano C; Harnor SJ; Hardcastle IR; Grundlingh J; Dargan PI; Wood DM; Tucker S; Bartram T; Thomas SHL
    Clin Chem; 2018 Feb; 64(2):346-354. PubMed ID: 29038156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal intoxication with synthetic cannabinoid MDMB-CHMICA.
    Adamowicz P
    Forensic Sci Int; 2016 Apr; 261():e5-10. PubMed ID: 26934903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015.
    Abouchedid R; Hudson S; Thurtle N; Yamamoto T; Ho JH; Bailey G; Wood M; Sadones N; Stove CP; Dines A; Archer JRH; Wood DM; Dargan PI
    Clin Toxicol (Phila); 2017 Jun; 55(5):338-345. PubMed ID: 28421836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspected synthetic cannabinoid receptor agonist intoxication: Does analysis of samples reflect the presence of suspected agents?
    Tebo C; Mazer-Amirshahi M; DeGeorge L; Gelfand B; Leak C; Tolliver S; Sauter D
    Am J Emerg Med; 2019 Oct; 37(10):1846-1849. PubMed ID: 30595429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project.
    Helander A; Beck O; Hägerkvist R; Hultén P
    Scand J Clin Lab Invest; 2013 Aug; 73(5):400-6. PubMed ID: 23692208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine.
    Helander A; Beck O; Bäckberg M
    Clin Toxicol (Phila); 2015 Jun; 53(5):446-53. PubMed ID: 25881797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act.
    Craft S; Dunn M; Vidler D; Officer J; Blagbrough IS; Pudney CR; Henderson G; Abouzeid A; Dargan PI; Eddleston M; Cooper J; Hill SL; Roper C; Freeman TP; Thomas SHL
    Addiction; 2022 Nov; 117(11):2899-2906. PubMed ID: 35665553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute toxicity following analytically confirmed use of the novel psychoactive substance (NPS) methiopropamine. A report from the Identification of Novel psychoActive substances (IONA) study.
    White JC; Wood DM; Hill SL; Eddleston M; Officer J; Dargan PI; Dunn M; Thomas SHL
    Clin Toxicol (Phila); 2019 Jul; 57(7):663-667. PubMed ID: 30676081
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemical profiling of the synthetic cannabinoid MDMB-CHMICA: Identification, assessment, and stability study of synthesis-related impurities in seized and synthesized samples.
    Münster-Müller S; Hansen S; Opatz T; Zimmermann R; Pütz M
    Drug Test Anal; 2019 Aug; 11(8):1192-1206. PubMed ID: 31124282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumyl-PEGACLONE: A comparatively safe new synthetic cannabinoid receptor agonist entering the NPS market?
    Halter S; Angerer V; Röhrich J; Groth O; Roider G; Hermanns-Clausen M; Auwärter V
    Drug Test Anal; 2019 Feb; 11(2):347-349. PubMed ID: 30468574
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse events related to the new psychoactive substance 3-fluorophenmetrazine - results from the Swedish STRIDA project.
    Bäckberg M; Westerbergh J; Beck O; Helander A
    Clin Toxicol (Phila); 2016 Nov; 54(9):819-825. PubMed ID: 27491700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the Psychoactive Substances Act 2016 on the online availability of MDMB-CHMICA.
    Haden M; Wood DM; Dargan PI
    QJM; 2017 Oct; 110(10):619-622. PubMed ID: 28339898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
    Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.